PDB2 TOTAL Cost of Care and Utilization Among Medicare Fee-for-Service (FFS) Patients with Metastatic Pancreatic Cancer Treated with FDA-Approved/NCCN® Category 1 Regimens at Teaching VS. NON-Teaching Hospitals

Subjects

Subjects :

medicine.medical_specialty
business.industry
Total cost
Health Policy
Internal medicine
Metastatic pancreatic cancer
Public Health, Environmental and Occupational Health
medicine
Fee-for-service
business

Details

ISSN :

10983015

Volume :

24

Database :

OpenAIRE

Journal :

Value in Health

Accession number :

edsair.doi...........4e6f32fad7ac45d815d8e71110a71a6a